ChromaDex Corporation

ChromaDex is pioneering research on nicotinamide adenine dinucleotide (NAD+), an essential coenzyme that is a key regulator of cellular metabolism. NAD+ levels in humans have been shown to decline with age, among other factors, & may be increased through supplementation with NAD+ precursors. ChromaDex is the innovator behind NAD+ precursor nicotinamide riboside (NR), commercialized as the flagship ingredient Niagen®. ChromaDex offers Niagen® as the active ingredient in its consumer product Tru Niagen® available at www.truniagen.com & through partnerships with global retailers & distributors.